A phase IIa trial of very low dose cyclobenzaprine in patients with fibromyalgia.

Trial Profile

A phase IIa trial of very low dose cyclobenzaprine in patients with fibromyalgia.

Completed
Phase of Trial: Phase II

Latest Information Update: 07 Sep 2011

At a glance

  • Drugs Cyclobenzaprine (Primary)
  • Indications Fibromyalgia
  • Focus Therapeutic Use
  • Sponsors Krele Pharmaceuticals Inc; Tonix Pharmaceuticals Inc
  • Most Recent Events

    • 07 Sep 2011 Status changed to completed, according to results published in a TONIX Pharmaceuticals media release.
    • 01 Sep 2011 Results published in The Journal of rheumatology.
    • 17 Jun 2011 Results have been presented at the Associated Professional Sleep Society 2011 Anniversary Meeting according to a TONIX Pharmaceuticals media release. Results were also reported in the media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top